@article{537bc629f1a44e0b8782839c2a970d18,
title = "Novel oral anticoagulants in gastroenterology practice",
keywords = "AF, ARISTOTLE, ASGE, American Society for Gastrointestinal Endoscopy, INR, NOAC, NSAID, PCC, PPI, PT, RE-LY, ROCKET-AF, RR, aPTT, activated partial thromboplastin time, apixaban for reduction in stroke and thromboembolic events in atrial fibrillation, atrial fibrillation, international normalized ratio, nonsteroidal anti-inflammatory drug, novel oral anticoagulant, prothrombin complex concentrate, prothrombin time, proton pump inhibitor, randomized evaluation of long term anticoagulant therapy, relative risk, rivaroxaban once daily oral direct factor Xa inhibition compared with vitamin K antagonism for prevention of stroke and embolism trial in atrial fibrillation",
author = "Jay Desai and Granger, {Christopher B.} and Weitz, {Jeffrey I.} and James Aisenberg",
year = "2013",
month = aug,
doi = "10.1016/j.gie.2013.04.179",
language = "English",
volume = "78",
pages = "227--239",
journal = "Gastrointestinal Endoscopy",
issn = "0016-5107",
publisher = "Mosby Inc.",
number = "2",
}